 | • レポートコード：MRC23Q37047 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（2-3日） • 産業分類：消費財 |
| Single User | ￥420,500 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥841,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の糖尿病患者用インソール市場について調査・分析し、世界の糖尿病患者用インソール市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（1型糖尿病患者用インソール、2型糖尿病患者用インソール、3型糖尿病患者用インソール）、用途別セグメント分析（運動靴、ブーツ、カジュアルシューズ、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Algeos、AliMed、Physipod、PowerStep、Implus(Spenco Medics)、Comfortland Medical、Atlantic Footcare、MEGA、Orthofeet、Apexfoot.、Scholl’s Wellness、Custom Feet Insoles、Pedors、SoleTech、Svorto、CuraFootなどが含まれています。世界の糖尿病患者用インソール市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、糖尿病患者用インソール市場規模を推定する際に考慮しました。本レポートは、糖尿病患者用インソールの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、糖尿病患者用インソールに関するビジネス上の意思決定に役立てることを目的としています。 ・糖尿病患者用インソール市場の概要 - 製品の定義 - 糖尿病患者用インソールのタイプ別セグメント - 世界の糖尿病患者用インソール市場規模：タイプ別分析（1型糖尿病患者用インソール、2型糖尿病患者用インソール、3型糖尿病患者用インソール） - 糖尿病患者用インソールの用途別セグメント - 世界の糖尿病患者用インソール市場規模：用途別分析（運動靴、ブーツ、カジュアルシューズ、その他） - 世界の糖尿病患者用インソール市場規模予測（2018年-2029年） - 糖尿病患者用インソールの平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 糖尿病患者用インソール市場の競争状況およびトレンド ・糖尿病患者用インソールの地域別市場規模 - 北米の糖尿病患者用インソール市場規模（2018年-2029年） - アメリカの糖尿病患者用インソール市場規模（2018年-2029年） - ヨーロッパの糖尿病患者用インソール市場規模（2018年-2029年） - アジア太平洋の糖尿病患者用インソール市場規模（2018年-2029年） - 中国の糖尿病患者用インソール市場規模（2018年-2029年） - 日本の糖尿病患者用インソール市場規模（2018年-2029年） - 韓国の糖尿病患者用インソール市場規模（2018年-2029年） - インドの糖尿病患者用インソール市場規模（2018年-2029年） - オーストラリアの糖尿病患者用インソール市場規模（2018年-2029年） - 中南米の糖尿病患者用インソール市場規模（2018年-2029年） - 中東・アフリカの糖尿病患者用インソール市場規模（2018年-2029年） ・タイプ別セグメント：1型糖尿病患者用インソール、2型糖尿病患者用インソール、3型糖尿病患者用インソール - 世界の糖尿病患者用インソールのタイプ別販売量（2018年-2023年） - 世界の糖尿病患者用インソールのタイプ別売上（2018年-2023年） - 世界の糖尿病患者用インソールのタイプ別価格 ・用途別セグメント：運動靴、ブーツ、カジュアルシューズ、その他 - 世界の糖尿病患者用インソールの用途別販売量（2018年-2023年） - 世界の糖尿病患者用インソールの用途別売上（2018年-2023年） - 世界の糖尿病患者用インソールの用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Algeos、AliMed、Physipod、PowerStep、Implus(Spenco Medics)、Comfortland Medical、Atlantic Footcare、MEGA、Orthofeet、Apexfoot.、Scholl’s Wellness、Custom Feet Insoles、Pedors、SoleTech、Svorto、CuraFoot ・産業チェーンと販売チャネルの分析 - 糖尿病患者用インソール産業チェーン分析 - 糖尿病患者用インソールの主要原材料 - 糖尿病患者用インソールの販売チャネル - 糖尿病患者用インソールのディストリビューター - 糖尿病患者用インソールの主要顧客 ・糖尿病患者用インソール市場ダイナミクス - 糖尿病患者用インソールの業界動向 - 糖尿病患者用インソール市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Diabetic Insoles market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Diabetic Insoles is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Diabetic Insoles is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Diabetic Insoles include Algeos, AliMed, Physipod, PowerStep, Implus(Spenco Medics), Comfortland Medical, Atlantic Footcare, MEGA and Orthofeet, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Diabetic Insoles, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetic Insoles.
The Diabetic Insoles market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Diabetic Insoles market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetic Insoles manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Algeos
AliMed
Physipod
PowerStep
Implus(Spenco Medics)
Comfortland Medical
Atlantic Footcare
MEGA
Orthofeet
Apexfoot.
Scholl’s Wellness
Custom Feet Insoles
Pedors
SoleTech
Svorto
CuraFoot
Segment by Type
Single Density Diabetic Insoles
Dual Density Diabetic Insoles
Triple Density Diabetic Insoles
Segment by Application
Athletic Shoes
Boots
Casual Shoes
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diabetic Insoles manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diabetic Insoles in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Diabetic Insoles Market Overview
1.1 Product Overview and Scope of Diabetic Insoles
1.2 Diabetic Insoles Segment by Type
1.2.1 Global Diabetic Insoles Market Value Comparison by Type (2023-2029)
1.2.2 Single Density Diabetic Insoles
1.2.3 Dual Density Diabetic Insoles
1.2.4 Triple Density Diabetic Insoles
1.3 Diabetic Insoles Segment by Application
1.3.1 Global Diabetic Insoles Market Value by Application: (2023-2029)
1.3.2 Athletic Shoes
1.3.3 Boots
1.3.4 Casual Shoes
1.3.5 Others
1.4 Global Diabetic Insoles Market Size Estimates and Forecasts
1.4.1 Global Diabetic Insoles Revenue 2018-2029
1.4.2 Global Diabetic Insoles Sales 2018-2029
1.4.3 Global Diabetic Insoles Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Diabetic Insoles Market Competition by Manufacturers
2.1 Global Diabetic Insoles Sales Market Share by Manufacturers (2018-2023)
2.2 Global Diabetic Insoles Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Diabetic Insoles Average Price by Manufacturers (2018-2023)
2.4 Global Diabetic Insoles Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Diabetic Insoles, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diabetic Insoles, Product Type & Application
2.7 Diabetic Insoles Market Competitive Situation and Trends
2.7.1 Diabetic Insoles Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Diabetic Insoles Players Market Share by Revenue
2.7.3 Global Diabetic Insoles Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Diabetic Insoles Retrospective Market Scenario by Region
3.1 Global Diabetic Insoles Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Diabetic Insoles Global Diabetic Insoles Sales by Region: 2018-2029
3.2.1 Global Diabetic Insoles Sales by Region: 2018-2023
3.2.2 Global Diabetic Insoles Sales by Region: 2024-2029
3.3 Global Diabetic Insoles Global Diabetic Insoles Revenue by Region: 2018-2029
3.3.1 Global Diabetic Insoles Revenue by Region: 2018-2023
3.3.2 Global Diabetic Insoles Revenue by Region: 2024-2029
3.4 North America Diabetic Insoles Market Facts & Figures by Country
3.4.1 North America Diabetic Insoles Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Diabetic Insoles Sales by Country (2018-2029)
3.4.3 North America Diabetic Insoles Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Diabetic Insoles Market Facts & Figures by Country
3.5.1 Europe Diabetic Insoles Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Diabetic Insoles Sales by Country (2018-2029)
3.5.3 Europe Diabetic Insoles Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diabetic Insoles Market Facts & Figures by Country
3.6.1 Asia Pacific Diabetic Insoles Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Diabetic Insoles Sales by Country (2018-2029)
3.6.3 Asia Pacific Diabetic Insoles Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Diabetic Insoles Market Facts & Figures by Country
3.7.1 Latin America Diabetic Insoles Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Diabetic Insoles Sales by Country (2018-2029)
3.7.3 Latin America Diabetic Insoles Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Diabetic Insoles Market Facts & Figures by Country
3.8.1 Middle East and Africa Diabetic Insoles Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Diabetic Insoles Sales by Country (2018-2029)
3.8.3 Middle East and Africa Diabetic Insoles Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Diabetic Insoles Sales by Type (2018-2029)
4.1.1 Global Diabetic Insoles Sales by Type (2018-2023)
4.1.2 Global Diabetic Insoles Sales by Type (2024-2029)
4.1.3 Global Diabetic Insoles Sales Market Share by Type (2018-2029)
4.2 Global Diabetic Insoles Revenue by Type (2018-2029)
4.2.1 Global Diabetic Insoles Revenue by Type (2018-2023)
4.2.2 Global Diabetic Insoles Revenue by Type (2024-2029)
4.2.3 Global Diabetic Insoles Revenue Market Share by Type (2018-2029)
4.3 Global Diabetic Insoles Price by Type (2018-2029)
5 Segment by Application
5.1 Global Diabetic Insoles Sales by Application (2018-2029)
5.1.1 Global Diabetic Insoles Sales by Application (2018-2023)
5.1.2 Global Diabetic Insoles Sales by Application (2024-2029)
5.1.3 Global Diabetic Insoles Sales Market Share by Application (2018-2029)
5.2 Global Diabetic Insoles Revenue by Application (2018-2029)
5.2.1 Global Diabetic Insoles Revenue by Application (2018-2023)
5.2.2 Global Diabetic Insoles Revenue by Application (2024-2029)
5.2.3 Global Diabetic Insoles Revenue Market Share by Application (2018-2029)
5.3 Global Diabetic Insoles Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Algeos
6.1.1 Algeos Corporation Information
6.1.2 Algeos Description and Business Overview
6.1.3 Algeos Diabetic Insoles Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Algeos Diabetic Insoles Product Portfolio
6.1.5 Algeos Recent Developments/Updates
6.2 AliMed
6.2.1 AliMed Corporation Information
6.2.2 AliMed Description and Business Overview
6.2.3 AliMed Diabetic Insoles Sales, Revenue and Gross Margin (2018-2023)
6.2.4 AliMed Diabetic Insoles Product Portfolio
6.2.5 AliMed Recent Developments/Updates
6.3 Physipod
6.3.1 Physipod Corporation Information
6.3.2 Physipod Description and Business Overview
6.3.3 Physipod Diabetic Insoles Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Physipod Diabetic Insoles Product Portfolio
6.3.5 Physipod Recent Developments/Updates
6.4 PowerStep
6.4.1 PowerStep Corporation Information
6.4.2 PowerStep Description and Business Overview
6.4.3 PowerStep Diabetic Insoles Sales, Revenue and Gross Margin (2018-2023)
6.4.4 PowerStep Diabetic Insoles Product Portfolio
6.4.5 PowerStep Recent Developments/Updates
6.5 Implus(Spenco Medics)
6.5.1 Implus(Spenco Medics) Corporation Information
6.5.2 Implus(Spenco Medics) Description and Business Overview
6.5.3 Implus(Spenco Medics) Diabetic Insoles Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Implus(Spenco Medics) Diabetic Insoles Product Portfolio
6.5.5 Implus(Spenco Medics) Recent Developments/Updates
6.6 Comfortland Medical
6.6.1 Comfortland Medical Corporation Information
6.6.2 Comfortland Medical Description and Business Overview
6.6.3 Comfortland Medical Diabetic Insoles Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Comfortland Medical Diabetic Insoles Product Portfolio
6.6.5 Comfortland Medical Recent Developments/Updates
6.7 Atlantic Footcare
6.6.1 Atlantic Footcare Corporation Information
6.6.2 Atlantic Footcare Description and Business Overview
6.6.3 Atlantic Footcare Diabetic Insoles Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Atlantic Footcare Diabetic Insoles Product Portfolio
6.7.5 Atlantic Footcare Recent Developments/Updates
6.8 MEGA
6.8.1 MEGA Corporation Information
6.8.2 MEGA Description and Business Overview
6.8.3 MEGA Diabetic Insoles Sales, Revenue and Gross Margin (2018-2023)
6.8.4 MEGA Diabetic Insoles Product Portfolio
6.8.5 MEGA Recent Developments/Updates
6.9 Orthofeet
6.9.1 Orthofeet Corporation Information
6.9.2 Orthofeet Description and Business Overview
6.9.3 Orthofeet Diabetic Insoles Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Orthofeet Diabetic Insoles Product Portfolio
6.9.5 Orthofeet Recent Developments/Updates
6.10 Apexfoot.
6.10.1 Apexfoot. Corporation Information
6.10.2 Apexfoot. Description and Business Overview
6.10.3 Apexfoot. Diabetic Insoles Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Apexfoot. Diabetic Insoles Product Portfolio
6.10.5 Apexfoot. Recent Developments/Updates
6.11 Scholl’s Wellness
6.11.1 Scholl’s Wellness Corporation Information
6.11.2 Scholl’s Wellness Diabetic Insoles Description and Business Overview
6.11.3 Scholl’s Wellness Diabetic Insoles Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Scholl’s Wellness Diabetic Insoles Product Portfolio
6.11.5 Scholl’s Wellness Recent Developments/Updates
6.12 Custom Feet Insoles
6.12.1 Custom Feet Insoles Corporation Information
6.12.2 Custom Feet Insoles Diabetic Insoles Description and Business Overview
6.12.3 Custom Feet Insoles Diabetic Insoles Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Custom Feet Insoles Diabetic Insoles Product Portfolio
6.12.5 Custom Feet Insoles Recent Developments/Updates
6.13 Pedors
6.13.1 Pedors Corporation Information
6.13.2 Pedors Diabetic Insoles Description and Business Overview
6.13.3 Pedors Diabetic Insoles Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Pedors Diabetic Insoles Product Portfolio
6.13.5 Pedors Recent Developments/Updates
6.14 SoleTech
6.14.1 SoleTech Corporation Information
6.14.2 SoleTech Diabetic Insoles Description and Business Overview
6.14.3 SoleTech Diabetic Insoles Sales, Revenue and Gross Margin (2018-2023)
6.14.4 SoleTech Diabetic Insoles Product Portfolio
6.14.5 SoleTech Recent Developments/Updates
6.15 Svorto
6.15.1 Svorto Corporation Information
6.15.2 Svorto Diabetic Insoles Description and Business Overview
6.15.3 Svorto Diabetic Insoles Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Svorto Diabetic Insoles Product Portfolio
6.15.5 Svorto Recent Developments/Updates
6.16 CuraFoot
6.16.1 CuraFoot Corporation Information
6.16.2 CuraFoot Diabetic Insoles Description and Business Overview
6.16.3 CuraFoot Diabetic Insoles Sales, Revenue and Gross Margin (2018-2023)
6.16.4 CuraFoot Diabetic Insoles Product Portfolio
6.16.5 CuraFoot Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diabetic Insoles Industry Chain Analysis
7.2 Diabetic Insoles Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diabetic Insoles Production Mode & Process
7.4 Diabetic Insoles Sales and Marketing
7.4.1 Diabetic Insoles Sales Channels
7.4.2 Diabetic Insoles Distributors
7.5 Diabetic Insoles Customers
8 Diabetic Insoles Market Dynamics
8.1 Diabetic Insoles Industry Trends
8.2 Diabetic Insoles Market Drivers
8.3 Diabetic Insoles Market Challenges
8.4 Diabetic Insoles Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer